Cranberry proanthocyanidins induce apoptosis and inhibit acid-induced proliferation of human esophageal adenocarcinoma cells

Journal of Agricultural and Food Chemistry

Volumn 56, Issue 3, 2008, Pages 676-680

  Kresty, Laura A ^a,b   Howell, Amy B ^a,b   Baird, Maureen ^a,b  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

Antiproliferative; Cell cycle; Cranberry proanthocyanidins; Esophageal cancer; SEG 1

Indexed keywords

ANTI-PROLIFERATIVE; CELL CYCLE; ESOPHAGEAL CANCER; PROANTHOCYANIDINS; SEG-1;

CELL CULTURE; CELL PROLIFERATION; DISEASES;

CELL DEATH;

ANIMALIA; VACCINIUM MACROCARPON;

EID: 80051854089     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf071997t     Document Type: Conference Paper

References (36)

1. Pera, M.; Cameron, A. J.; Trastek, V. F.; Carpenter, H. A.; Zinsmeister, A. R. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 1993, 104, 510-513. (Pubitemid 23033424)
2. Devesa, S. S.; Blot, W. J.; Fraumeni, J. F. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998, 83, 2049-2053. (Pubitemid 28525384)
3. Blot, W. J.; McLaughlin, J. K. The changing epidemiology of esophageal cancer. Semin. Oncol. 1999, 26, 2-8. (Pubitemid 29529530)
4. Cancer Facts & Figures; American Cancer Society: Atlanta, GA, 2007.
5. Conio, M.; Filiberti, R.; Blanchi, S.; Ferraris, R.; Marchi, S.; Ravelli, P.; Lapertosa, G.; Iaquinto, G.; Sablich, R.; Gusmaroli, R.; Aste, H.; Giacosa, A. Risk factors for Barrett's esophagus: a case control study. Int. J. Cancer 2002, 97, 225-229. (Pubitemid 34019959)
6. Lagergren, J.; Bergstrom, R.; Lindgren, A.; Nyren, O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N. Engl. J. Med. 1999, 340, 825-831. (Pubitemid 29142625)
7. Reid, B. J. Barrett's esophagus and esophageal adenocarcinoma. Gastroenenterol. Clin. North Am. 1991, 20, 817-834.
8. Chow, W. H.; Blot, W. J.; Vaughan, T. L.; Risch, H. A.; Gammon, M. D.; Stanford, J. L.; Dubrow, R.; Schoenberg, J. B.; Mayne, S. T.; Farrow, D. C.; Ahsan, H.; West, A. B.; Rotterdam, H.; Niwa, S.; Fraumeni, J. F., Jr. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J. Natl. Cancer Inst. 1998, 90, 150-155. (Pubitemid 28114417)
9. Lagergren, J.; Bergstrom, R.; Nyren, O. Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann. Intern. Med. 1999, 130, 883-890. (Pubitemid 29239582)
10. Mayne, S. T.; Navarro, S. A. Diet, obesity and reflux in the etiology of adenocarcinomas of the esophagus and gastric cardia in humans. J. Nutr. 2002, 132, 3467S-3470S. (Pubitemid 35315822)
11. Calle, E. E.; Rodriguez, C.; Walker-Thurmond, K.; Thun, M. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N. Engl. J. Med. 2003, 348, 1625- 1638. (Pubitemid 36459468)
12. Chen, H.; Tucker, K. L.; Graubard, B. I.; Heineman, E. F.; Markin, R. S.; Potischman, N. A.; Russell, R. M.; Weisenburger, D. D.; Ward, M. H. Nutrient intakes and adenocarcinoma of the esophagus and distal stomach. Nutr. Cancer 2002, 42, 33-40. (Pubitemid 35007004)
13. Engel, L. S.; Chow, W.-H.; Vaughan, T. L.; Gammon, M. D.; Risch, H. A.; Stanford, J. L.; Schoenberg, J. B.; Mayne, S. T.; Dubrow, R.; Rotterdam, H.; West, B.; Blaser, M.; Blot, W. J.; Gail, M. H.; Fraumeni, J. F., Jr. Population attributable risks of esophageal and gastric cancers. J. Natl. Cancer. Inst. 2003, 95, 1404-1413. (Pubitemid 37220460)
14. Mayne, S. T.; Risch, H. A.; Dubrow, R.; Chow, W.-H.; Gammon, M. D.; Vaughan, T. L.; Farrow, D. C.; Schoenberg, J. B.; Stanford, J. L.; Ahsan, H.; West, A. B.; Rotterdam, H.; Blot, W. J.; Fraumeni, J. F. Nutrient intake and risk of subtypes of esophageal and gastric cancer. Cancer Epidemiol. Biomarkers PreV. 2001, 10, 1055-1062. (Pubitemid 32959152)
15. Holmes, R. S.; Vaughan, T. L. Epidemiology and pathogenesis of esophageal cancer. Semin. Radiat. Oncol. 2007, 17, 2-9. (Pubitemid 44918357)
16. Bahmanyar, S.; Ye, W. Dietary patterns and risk of squamouscell carcinoma and adenocarcinoma of the esophagus and adenocarcinoma of the gastric cardia: a population-based case-control study in Sweden. Nutr. Cancer 2006, 54, 171-178. (Pubitemid 44316299)
17. Terry, P.; Lagergren, J.; Ye, W.; Wolk, A.; Nyren, O. Inverse association between intake of cereal fiber and risk of gastric cardia cancer. Gastroenterology 2001, 120, 387-391. (Pubitemid 32147636)
18. Howell, A. B.; Reed, J. D.; Krueger, C. G.; Winterbottom, R.; Cunningham, D. G.; Leahy, M. A-type proanthocyanidins and uropathogenic bacterial anti-adhesion activity. Phytochemistry 2005, 66, 2281-2291. (Pubitemid 41254101)
19. Howell, A. B.; Leahy, M.; Kurowska, E.; Gurthie, N. In vivo evidence that cranberry proanthocyanidins inhibit adherence of p-fibriated E. coli bacteria to uroepithelial cells. FASEB J. 2001, 15, A284.
20. Foo, L. Y.; Lu, Y.; Howell, A. B.; Vorsa, N. The structure of cranberry proanthocyanidins which inhibit adherence of uropathogenic P-fimbriated Escherichia coli in vitro. Phytochemistry 2000, 54, 173-181. (Pubitemid 30350852)
21. Foo, L. Y.; Lu, Y.; Howell, A. B.; Vorsa, N. A-type proanthocyanidin trimers from cranberry that inhibit adherence of uropathogenic P-fimbriated Escherichia coli. J. Nat. Prod. 2000, 63, 1225-1228.
22. Neto, C. C. Cranberry and its phytochemicals: a review of in vitro anticancer studies. J. Nutr. 2007, 137, 186S-193S. (Pubitemid 46052879)
23. Sun, J.; Liu, R. H. Cranberry phytochemical extracts induce cell cycle arrest and apoptosis in human MCF-7 breast cells. Cancer Lett. 2006, 241, 124-134.
24. Seeram, N. P.; Adams, L. S.; Zang, Y.; Lee, R.; Sand, D.; Scheuller, H. S.; Heber, D. Blackberry, black raspberry, blueberry, cranberry, red raspberry, and strawberry extracts inhibit growth and stimulate apoptosis if human cancer cells in vitro. J. Agric. Food Chem. 2004, 52, 2512-2517.
25. Seeram, N. P.; Adams, L. S.; Hardy, M. L.; Heber, D. Total cranberry extract versus its phytochemical constituents: antiproliferative and synergistic effects against human tumor cell lines. J. Agric. Food Chem. 2006, 54, 9329-9339.
26. Murphy, B. T.; MacKinnon, S. L.; Yan, X.; Hammond, G. B.; Vaisberg, A. J.; Neto, C. C. Idenification or triterpene hydroxycinnamates with in vitro antitumor activity from whole cranberry fruit (Vaccinium macrocarpon). J. Agric. Food Chem. 2003, 51, 3541-3545.
27. Ferguson, P. J.; Kurowska, E.; Freeman, D. J.; Chambers, A. F.; Koropatnick, D. J. A flavonoid fraction from cranberry extract inhibits proliferation of human tumor cell lines. Nutr. Cancer 2004, 56, 1529-1535. (Pubitemid 38720734)
28. Ferguson, P. J.; Kurowska, E. M.; Freeman, D. J.; Chambers, A. F.; Koropatnick, J. In vivo inhibition of growth of human tumor lines by flavonoid fractions from cranberry extract. Nutr. Cancer 2006, 56, 86-94. (Pubitemid 46173418)
29. Kresty, L. A.; Morse, M. A.; Morgan, C.; Carlton, P. S.; Lu, J.; Gupta, A.; Blackwood, M.; and Stoner, G. D. Chemoprevention of esophageal tumorigenesis by dietary administration of lyophilized black raspberries. Cancer Res. 2001, 61, 6112-6119. (Pubitemid 32762547)
30. Kresty, L. A.; Frankel, W. L.; Hammond, C. D.; Baird, M. E.; Mele, J. M.; Stoner, G. D.; Fromkes, J. J. Transitioning from preclinical to clinical chemopreventive assessments of lyophilized black raspberries: interim results show berries modulate markers of oxidative stress in Barrett's esophagus patients. Nutr Cancer. 2006, 54, 148-56. (Pubitemid 44141344)
31. Darzynkiewicz, Z.; Bruno, S.; del Bino, G.; et al. Features of apoptotic cells measured by flow cytometry. Cytometry 1992, 13, 795-808.
32. Jaiswal, K.; Tello, V.; Lopez-Guzman, C.; Nwariaku, F.; Anthony, T.; Sarosi, G. A. Bile salt exposure causes phosphatidyl-inositol- 3-kinase-mediated proliferation in a Barrett's adenocarcinoma cell line. Surgery 2004, 136, 160-168. (Pubitemid 39037649)
33. Souza, R. F.; Shewmake, K.; Terada, L. S.; Spechler, S. J. Acid exposure activates the mitogen-activated protein kinase pathways in Barrett's esophagus. Gastroenterology 2002, 122, 299-307. (Pubitemid 34126346)
34. Sarosi, G. A., Jr.; Jaiswal, K.; Herndon, E.; Lopez-Guzman, C.; Spechler, S. J.; Souza, R. F. Acid increases MAPK-mediated proliferation in Barrett's esophageal adenocarcinoma cells via intracellular acidification through a Cl-/HCO3- exchanger. Am. J. Physiol. Gastrointest. LiVer Physiol. 2005, 289, G991-G997. (Pubitemid 41740602)
35. Fitzerald, R. C. Barrett's oesophagus and oesophageal adenocarcinoma: how does acid interfere with cell proliferation and differentiation. Gut 2005, 54S, I21-126.
36. Morgan, C.; Alazawi, W.; Sirieix, P.; Freeman, T.; Coleman, N.; Fitzgerald, R. In vitro acid exposure has a differential effect on apoptotic and proliferative pathways in a Barrett's adenocarcinoma cell line. Am. J. Gastroenterol. 2004, 99, 218-224. (Pubitemid 38279860)